Exclusive

Publication

Byline

Antara Senior Living to launch new services for elderly as part of revamp

New Delhi, July 14 -- Max India Ltd's subsidiary Antara Senior Living is set to launch its new projects Care Home and Care at Home this week as part of the company's attempt to revamp its business und... Read More


Glenmark slashes covid-19 drug FabiFlu price by 27% to Rs 75 a pill

New delhi, July 14 -- Glenmark Pharmaceuticals Ltd announced on Monday that it has reduced the price of its covid-19 drug FabiFlu by 27% to Rs.75 per pill. The branded generic of favipiravir was earli... Read More


Govt finalising guidelines for scheme to boost API manufacturing

New Delhi, July 13 -- With an eye on reducing the dependence of raw material import from China, the department of pharmaceuticals is finalising guidelines for the production linked incentive (PLI) sch... Read More


Biocon Biologics set to ramp up production of itolizumab

New Delhi, July 13 -- Biocon Biologics India Ltd will ramp up its capacity to produce itolizumab to avoid any shortage of the drug, which received approval from the Drug Controller General of India (D... Read More


Biocon arm to ramp-up Itolizumab production after DCGI nod for covid-19 treatment

New Delhi, July 13 -- Biocon Biologics India Ltd will ramp up its capacity to produce itolizumab at its plant to avoid any shortage of the drug, which late last week received an approval from the Drug... Read More


Glenmark slashes covid drug FabiFlu price by 27% to Rs.75 per tablet

NEW DELHI, July 13 -- Glenmark Pharmaceuticals Ltd on Monday said it has reduced the price of its covid-19 drug FabiFlu by 27% to Rs.75 per tablet. The branded generic of favipiravir was earlier sold ... Read More


Biocon Biologics' itolizumab gets DCGI nod for emergency use to treat covid-19

NEW DELHI, July 11 -- Biocon Ltd's subsidiary has received an emergency use authorisation (EUA) for its monoclonal antibody Itoliuzumab from the Drug Controller General of India to treat cytokine stor... Read More


Covid vaccine won't aid financials but may boost industry's reputation: Moody's

NEW DELHI, July 10 -- Research and development programmes for vaccines against covid-19 are unlikely to aid financials of pharmaceutical firms but the successful introduction of a vaccine to combat on... Read More


Pharma sales recover in June after decline in April and May

New Delhi, July 10 -- Sales of medicines recorded a growth of 2.4% year on year (y-o-y) in June, indicating a recovery from two consecutive months of decline caused by the lockdown to prevent the spre... Read More


Covaxin's clinical trials see high interest from volunteers

New Delhi, July 8 -- India's first human trial for a covid-19 vaccine candidate, Covaxin, which is being jointly developed by Bharat Biotech International Ltd and the Indian Council of Medical Researc... Read More